BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22971963)

  • 1. Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan.
    Kawamura T; Usui J; Kaseda K; Takada K; Ebihara I; Ishizu T; Iitsuka T; Sakai K; Takemura K; Kobayashi M; Koyama A; Kanemoto K; Sumazaki R; Uesugi N; Noguchi M; Nagata M; Suka M; Yamagata K
    Clin Exp Nephrol; 2013 Apr; 17(2):248-54. PubMed ID: 22971963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records.
    Nakagawa N; Kimura T; Sakate R; Isaka Y; Narita I
    Clin Exp Nephrol; 2023 Nov; 27(11):928-935. PubMed ID: 37515698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.
    Nakagawa N; Hasebe N; Hattori M; Nagata M; Yokoyama H; Sato H; Sugiyama H; Shimizu A; Isaka Y; Maruyama S; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):797-807. PubMed ID: 29214407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
    Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
    Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
    PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary nephrotic syndrome during childhood in Turkey.
    Ozkaya N; Cakar N; Ekim M; Kara N; Akkök N; Yalçinkaya F
    Pediatr Int; 2004 Aug; 46(4):436-8. PubMed ID: 15310309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
    Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).
    Urushihara M; Sato H; Shimizu A; Sugiyama H; Yokoyama H; Hataya H; Matsuoka K; Okamoto T; Ogino D; Miura K; Hamada R; Hibino S; Shima Y; Yamamura T; Kitamoto K; Ishihara M; Konomoto T; Hattori M;
    Clin Exp Nephrol; 2021 Sep; 25(9):1018-1026. PubMed ID: 34047871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
    Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis.
    Çaltik Yilmaz A; Aydog Ö; Akyüz SG; Bülbül M; Demircin G; Öner A
    Ren Fail; 2014 Sep; 36(8):1221-5. PubMed ID: 25065413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
    Taguchi T; Bohle A
    Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive study of individuals with membranoproliferative glomerulonephritis.
    Lu DF; McCarthy AM; Lanning LD; Delaney C; Porter C
    Nephrol Nurs J; 2007; 34(3):295-302; quiz 303. PubMed ID: 17644874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial foam cells in renal biopsies: an aid in differentiating idiopathic membranoproliferative glomerulonephritis (type I) and membranoproliferative glomerulonephritis associated with systemic lupus erythematosus.
    Poucell S; Thorner P; Balfe JW; Baumal R
    Child Nephrol Urol; 1988-1989; 9(1-2):106-11. PubMed ID: 3251613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.
    Nakano M; Karasawa K; Moriyama T; Uchida K; Nitta K
    Clin Exp Nephrol; 2019 Jun; 23(6):852-858. PubMed ID: 30854618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of adolescent-onset nephrotic syndrome in Indian children.
    Gulati S; Sural S; Sharma RK; Gupta A; Gupta RK
    Pediatr Nephrol; 2001 Dec; 16(12):1045-8. PubMed ID: 11793097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.
    Yamabe H; Johnson RJ; Gretch DR; Fukushi K; Osawa H; Miyata M; Inuma H; Sasaki T; Kaizuka M; Tamura N
    J Am Soc Nephrol; 1995 Aug; 6(2):220-3. PubMed ID: 7579088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
    Andeen NK; Jefferson JA; Akilesh S; Alpers CE; Bissonnette ML; Finn LS; Higgins J; Houghton DC; Kambham N; Magil A; Najafian B; Nicosia RF; Troxell ML; Smith KD
    Hum Pathol; 2018 Nov; 81():272-280. PubMed ID: 30420049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.